Back Pain clinical trials at UC Davis

2 in progress, 1 open to eligible people

Showing trials for

  • Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

    open to eligible people ages 18 years and up

    The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.

    Sacramento, California and other locations

  • Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome

    Sorry, not yet accepting patients

    This study will evaluate the clinical and biological effects of acupuncture for chronic low back pain associated with myofascial pain syndrome (MPS). In this randomized, participant- and assessor-blinded clinical trial, 64 adults with chronic low back pain due to MPS will be assigned to receive either true acupuncture or sham acupuncture for eight weeks. Participants will undergo total-body positron emission tomography/computed tomography (TB-PET/CT) imaging and complete standardized pain and functional questionnaires at baseline and after treatment. The study will evaluate whether acupuncture improves pain and function compared with sham treatment and whether TB-PET/CT imaging can detect changes in myofascial tissue metabolism and perfusion that correspond with clinical outcomes.

    Sacramento, California

Our lead scientists for Back Pain research studies include .

Last updated: